Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Lubricoat 0: Filed an IDE to begin a Phase I pilot study of 25 patients. Johnson & Johnson has exclusive worldwide marketing rights for adhesion prevention and

Lifecore Biomedical Inc. (LCBM), Chaska,

Read the full 51 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE